Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
We Are Available 24/ 7. Call Now.
Morgan Stanley Maintains Royalty Pharma (RPRX) Overweight Recommendation
Fintel reports that on April 10, 2023, Morgan Stanley maintained coverage of Royalty Pharma (NASDAQ:RPRX) with a Overweight recommendation. Analyst Price Forecast Suggests 48.83% Upside
Sabine Royalty Trust (SBR) Declares $0.70 Dividend
Sabine Royalty Trust said on April 6, 2023 that its board of directors declared a regular monthly dividend of $0.70 per share ($8.39 annualized). Previously,
Thursday Sector Laggards: Rental, Leasing, & Royalty, Hospital & Medical Practitioners
In trading on Thursday, rental, leasing, & royalty shares were relative laggards, down on the day by about 1.9%. Helping drag down the group were